Eagle Pharmaceuticals, Inc. Shareholders' Equity
Eagle Pharmaceuticals, Inc. had Shareholders' Equity of $252.04 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-08-09
- 2023-06-30: Stockholders' Equity Attributable to Parent $252.04M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $242.84M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $233.56M.
- 2022-09-30: Stockholders' Equity Attributable to Parent $231.78M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-06-30 | $252.04M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $242.84M 10-Q/A · filed 2023-08-09 | |
| 2022-12-31 | $233.56M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $231.78M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $237.98M 10-Q/A · filed 2023-08-09 | |
| 2022-03-31 | $215.96M 10-Q/A · filed 2023-08-09 | |
| 2021-12-31 | $176.45M 10-Q/A · filed 2023-08-09 | |
| 2021-09-30 | $185.29M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $194.85M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $191.08M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $186.01M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $172.79M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $183.96M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $181.83M 10-Q · filed 2021-08-09 | |
| 2019-12-31 | $179.17M 10-K · filed 2023-03-23 | |
| 2019-09-30 | $175.76M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $172.48M 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $175.36M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $160.76M 10-K · filed 2022-03-08 | |
| 2018-09-30 | $194.06M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $185.73M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $178.18M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $179.14M 10-K · filed 2021-03-05 | |
| 2017-09-30 | $171.08M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $165.36M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $166.83M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $151.23M 10-K · filed 2020-03-02 | |
| 2016-09-30 | $105.52M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $107.83M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $92.32M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $90.34M 10-K · filed 2019-02-28 | |
| 2015-09-30 | $87.63M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $96.45M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $102.88M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $27.91M 10-K · filed 2018-02-26 | |
| 2014-09-30 | $33.10M 10-K · filed 2017-03-15 | |
| 2014-06-30 | $41.91M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $44.69M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | -$87.93M 10-K · filed 2017-03-15 | -$87.93M 10-Q · filed 2014-05-15 |
| 2012-09-30 | -$93.43M 10-K · filed 2016-02-29 | |
| 2011-09-30 | -$71.17M 10-K · filed 2014-12-22 |